Log in
Sign up
Wuhan More Biotechnology Co., Ltd.

Wuhan More Biotechnology Co., Ltd.

A high-tech company specializing in researching and developing medical diagnostic products.

OverviewStructured DataIssuesContributorsActivity
Contents

Wuhan More Biotechnology specializes in developing precise diagnostic products for many illnesses, including cardiovascular and cerebrovascular diseases and cancer. This company is committed to independent research & development in the fields of Mechanical Automation, Molecular Biology, Microfluidics, Clinical Medicine and more.

Wuhan HealthCare Biotechnology Co., Ltd. is located in Wuhan Optics Valley Bio-Lake, National Bio-Industry Base. The company is a high-tech enterprise integrating R&D, production, sales and testing services with the strategic direction of precise medical diagnosis products for major diseases such as cancer, cardiovascular and cerebrovascular diseases.

Since its inception, the company has been committed to providing more efficient diagnostic products, with emphasis on independent research and development, and has established multi-disciplinary R&D teams in Clinical Medicine, Molecular Biology, Microfluidics, Mechanical Automation and other disciplines. The company has more than 10 invention patents and its torchbearer FastProbe® fluorescence in situ hybridization probe preparation technology with full independent intellectual property rights is at the international front level. Based on this patented technology, the new generation of probe hybridization incubation time is only 2 hours, shortening the fluorescence in situ hybridization detection time from 3 days to a few hours, with higher sensitivity, specificity and bright signal to noise ratio.

At the same time, the company has built a complete domestic and international marketing system and FastProbe® has entered more than 20 countries, and regions oversea, won a good market reputation and wide customer recognition, and become a leading brand of fast fluorescence in situ hybridization probe in the world.

Adhering to the tenet of “Fastness, Precision, and Beyond Expectation”, the company has been working tirelessly to contribute to the development of precision medical care worldwide.

With reverence and respect for life, we chose the health industry, which means we bear the mission and responsibility to protect health. Prompting us to redouble our efforts, with modern biomedical technology, stand on the shoulders of our predecessors to achieve technological innovation with excellent quality product, customer and patient services.

With the desire and noble ideal of self-realization, we chose Wuhan HealthCare Biotechnology Co., Ltd., which means that we carry the mission and responsibility of team growth and common development. This urge us honesty, dedication, tolerance, collaboration, uninterrupted learning and hardworking to stand in the industry development forefront and achieve our business model innovation. With outstanding performance, excellent results, return the capital and reward the society.

Our Mission: The Pursuit of Excellence, The Protection of Human Health.

Our Core Values: Integrity, Professionalism, Tolerance, Cooperation.

Our Vision: Create a Biomedical Technology Innovation Centre and set a benchmark for health care industry enterprises.

Timeline

No Timeline data yet.

Funding Rounds

Open in Query Tool

Products

Open in Query Tool

Acquisitions

Open in Query Tool

SBIR/STTR Awards

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

healthcare-biotech.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Healthcare
Healthcare
Diagnosis
Diagnosis
Medical device
Medical device
Health technology
Health technology
Location
Wuhan
Wuhan
China
China
B2X
B2B
B2B
CEO
‌
Chen Gang
Number of Employees (Ranges)
51 – 200
Full Address
Wuhan Optics Valley Biolake No. 666, Gaoxin Boulevard, East Lake High-tech Development Zone , Optics Valley Biolake, Building B6, 4/5 Floors, , Wuhan, Hubei 430075, CN
Investors
Sinopharm Capital
Sinopharm Capital
Total Funding Amount (USD)
4,540,000
Latest Funding Round Date
March 2019
Latest Funding Type
Series B round
Series B round

Other attributes

Company Operating Status
Active

Find more companies like Wuhan More Biotechnology Co., Ltd.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
Knowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseChatGPT Plugin
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.